Transcription of Non-vitamin K Antagonist Oral Anticoagulant (NOAC) …
{{id}} {{{paragraph}}}
Example: dental hygienist
Non-vitamin K Antagonist Oral Anticoagulant (NOAC) …
NOAC GUIDELINES Non-vitamin K Antagonist ORAL Anticoagulant UPDATED JULY 2017 Non-vitamin K Antagonist Oral Anticoagulants (NOAC) Guidelines | Page 2 Clinical Excellence Commission Updated July 2017 The CEC acknowledges the NSW Health Directors of Clinical Governance who commissioned this guideline and the efforts of the members of the Anticoagulant Medicines Working Party who contributed to its development. Clinical Excellence Commission, 2017, Non-vitamin K Antagonist Oral Anticoagulant (NOAC) Guidelines are available at: Clinical Excellence Commission 2017 All rights are reserved.
Non-Vitamin K antagonist oral anticoagulants (NOAC) are now widely used in patients with non-valvular atrial fibrillation (AF) and for the treatment and prevention of venous thromboembolism (VTE) in NSW Health facilities. NOACs include dabigatran, (direct thrombin inhibitor), apixaban and rivaroxaban (Factor Xa inhibitors). The term
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: